Metric | Estimates | Actuals | Surprise |
---|---|---|---|
Revenue | $245.0K | $0.0 | MISS by 100.0% |
EPS | ($2.74) | ($2.90) | MISS by 6.0% |
Sep'17 | Dec'17 | Mar'18 | Jun'18 | Sep'18 | Dec'18 | Mar'19 | Jun'19 | Sep'19 | Dec'19 | Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue actual | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $862.4K | $1,824.7K | $827.6K | $416.5K | $250.6K | $444.5K | $1,200.8K | $1,635.3K | $603.1K | $207.5K | $279.4K | $1,433.5K | $789.6K | $490.5K | $435.4K | $515.0K | $305.7K | $181.8K | $0.0 | $0.0 |
Revenue estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $1,200.0K | $800.0K | $1,200.0K | $1,000.0K | $1,000.0K | $1,540.0K | $950.0K | $760.0K | $593.3K | $395.0K | $400.0K | $300.0K | $3,400.0K | $245.0K |
Revenue surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 104.4% | 49.7% | 79.3% | 72.1% | 6.9% | 16.9% | 35.5% | 26.6% | 30.4% | 23.6% | 39.4% | 100.0% | 100.0% |
EPS actual | ($0.19) | ($1.43) | $0.07 | $0.07 | $0.10 | $0.12 | $0.13 | $0.14 | $0.08 | ($0.11) | ($0.05) | ($10.72) | $23.90 | $3.26 | ($14.40) | ($13.99) | ($169.83) | ($100.00) | $25.65 | ($62.35) | ($84.13) | ($8.46) | ($1.73) | ($0.98) | ($0.87) | ($1.55) | ($0.55) | ($0.22) | $0.07 | ($2.90) |
EPS estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ($8.52) | $1.08 | ($1.92) | ($2.04) | ($1.92) | ($28.88) | ($76.15) | ($27.80) | ($15.85) | ($13.05) | ($13.50) | ($5.85) | $1.05 | ($2.74) |
EPS surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1,893.3% | 9,359.3% | 1,435.9% | 2,956.4% | 4,281.8% | 70.7% | 97.7% | 96.5% | 94.5% | 88.1% | 95.9% | 96.2% | 93.6% | 6.0% |
Company name | Market Cap | Revenue | EPS | Last quarter Revenue growth | Last quarter EPS growth | Last quarter Revenue surprise | Last quarter EPS surprise | Next quarter Revenue growth | Next quarter EPS growth | Last 10 Earnings (how many miss vs beat) | 1Y Fwd Revenue growth | 1Y Fwd EPS growth |
$4,609.2K | $487.5K | ($3.60) | (100.0%) | 87.1% | undefinedN/A | undefinedN/A | 0.0% | 5.0% | Beats: 7 Misses: 3 | N/A | (99.9%) | |
$132.4B | $11.0B | ($2.06) | 15.7% | (5.6%) | undefinedN/A | undefinedN/A | (1.7%) | 20.2% | Beats: Misses: | 8.6% | (962.4%) | |
$72.4B | $14.2B | $40.88 | 10.3% | (21.6%) | undefinedN/A | undefinedN/A | (10.2%) | 9.3% | Beats: 8 Misses: 2 | 2.4% | 3.1% | |
$36.9B | $3,154.8M | $11.71 | 219.9% | N/A | undefinedN/A | undefinedN/A | (45.6%) | (83.5%) | Beats: 7 Misses: 3 | 76.3% | (132.2%) | |
$32.2B | $2,248.2M | ($2.17) | 34.9% | (40.9%) | undefinedN/A | undefinedN/A | (0.4%) | 45.9% | Beats: 8 Misses: 2 | 28.6% | (26.5%) | |
$23.9B | €2,751.1M | (€3.84) | (19.5%) | (100.0%) | undefinedN/A | undefinedN/A | (79.9%) | 0.0% | Beats: 5 Misses: 5 | (28.0%) | (182.9%) | |
$14.9B | $2,263.9M | $2.31 | (0.3%) | (58.6%) | undefinedN/A | undefinedN/A | 22.5% | 132.0% | Beats: 5 Misses: 5 | 35.4% | 144.6% | |
$14.6B | $0.0 | ($0.31) | (100.0%) | 62.6% | undefinedN/A | undefinedN/A | 0.0% | (8.4%) | Beats: 6 Misses: 4 | N/A | 11.4% | |
$14.4B | $2,877.4M | $26.45 | 19.7% | 45.9% | undefinedN/A | undefinedN/A | (0.9%) | (3.0%) | Beats: 7 Misses: 3 | 9.1% | 6.8% | |
$13.7B | $2,850.5M | $2.25 | 15.6% | 490.9% | undefinedN/A | undefinedN/A | (0.9%) | 7.4% | Beats: 8 Misses: 2 | 10.0% | 48.9% |
Ensysce Biosciences, Inc.'s last earnings date was Sep'24 (Q4 2024).
Ensysce Biosciences, Inc.'s EPS was ($2.90), with a 6.0% miss.
Ensysce Biosciences, Inc.'s revenue was $0.0, with a 100.0% miss.
Ensysce Biosciences, Inc.'s next quarter EPS estimate is ($2.74), with an expected (83.8%) YoY growth.